Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

November 29, 2017 Leave a comment 3,854 Views

Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Cosine

Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

SNuBar-ATAC – simple oligonucleotide-based multiplexing of single-cell chromatin accessibility

Single cell RNA sequencing based identification and profiling of Leishmania parasitized host cells

Direct RNA sequencing reveals SARS-CoV-2 m6A sites

Single-cell RNA sequencing identifies of early-stage lung cancer biomarkers from circulating blood

scRNA-seq – Introduction to single cell RNA-seq data analysis

m6A-seq2 – multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution

Scientists use m6A RNA sequencing to gain new understanding of how brain cells talk